Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Sales Of Sinclair Pharma's Silhouette InstaLift-Off

Executive Summary

Aesthetics company Sinclair Pharma has reported headline growth of 51% in 2016 due to strong unexpected interest for its Silhouette Instalift product.

You may also be interested in...



Investor Eye: Howard Rowe, Hayfin Capital Management – The Specialized Health Care Lenders

In this edition of Investor Eye, Medtech Insight meets with Howard Rowe, managing director and head of health care at Hayfin Capital Management, a $17bn international asset management firm headquartered in London.

Sinclair Pharma Bullish About Profitability By Year-End

Encouraged by its solid sales performance in the first half of this year, UK aesthetics company Sinclair Pharma is optimistic it can close out 2017 with a small profit. The firm's H1 revenues were boosted by continued growth in key markets, leading to a 16% top-line growth.

Sinclair Pharma's Non-Surgical Facelift Gains Access To US Market Via Thermigen Deal

Sinclair Pharma has gained access to the world’s largest aesthetics market by enlisting Thermigen as the exclusive US distributor of Silhouette InstaLift, a non-surgical alternative to facelifts.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT104325

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel